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Background: Increased access to transportation and information has led to the emer-
gence of more diverse patient choice and new forms of health care consumption, such 
as medical travel. In order for health care providers to effectively attract patients, more 
knowledge is needed on the mechanisms underlying decision-making of potential trav-
elers from different countries. A particularly promising method of studying the travelers’ 
motives is collecting data on social media.
Objectives: The aim of this study was to test what factors influence decision-making of 
potential medical travelers and how these factors interact. Based on existing literature, 
the factors analyzed included quality, cost, and waiting time for 2 procedures varying in 
invasiveness across 12 different destination countries.
Methods: Decision-making patterns were examined using a pilot questionnaire that 
generated a large amount of data from over 800 participants in 40 countries. Participants 
indicated their willingness to travel given different scenarios. Each scenario consisted of 
a combination of several factors. Additionally, participants were asked to indicate the 
reasons for their choice.
Results: Individuals display high willingness to travel for medical care when combining all 
participants and scenarios, travel for care was chosen 66.9% of the time. Among the factors 
influencing their decisions, quality of the medical procedure abroad was considered most 
important, and cost was least important as shown by chi-square tests and corresponding 
odds ratios. Log-linear analyses revealed an interaction between time waiting in the local 
health care system and type of procedure, whereby time pressure increased the odds of 
agreeing to travel for the more invasive procedure. The odds of traveling to Europe and the 
USA were by far the highest, although participants indicated that under certain conditions 
they might be willing to travel to other medical destinations, such as Asia.
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Conclusion: Our measurements yielded several reliable insights into the factors driving 
medical decision-making. An essential next step would be to expand these findings with 
a more encompassing sample and more elaborate statistical modeling.
Keywords: medical travel, public health policy, decision-making, destination, cost, quality, factors
for medical care, it is not clear which factors have more influence 
and whether they interact with each other to influence decision-
making. To address this lack of evidence (20), we investigated 
which factors influence individuals’ decision for or against obtain-
ing medical care abroad the most and how these factors interact 
with each other. The factors included the location of the destination 
clinic, waiting time, cost, quality, and invasiveness of the procedure. 
A survey, covering a large number of hypothetical medical travel 
decisions constructed as combinations of the factors mentioned 
above, was used to elucidate the structure of decision-making of 
potential medical travelers from various geographical regions.
MATERIALS AND METHODS
Study Design
A binary (Yes/No) questionnaire was developed in order to assess 
under which circumstances people would decide in favor or 
against medical travel. The design of the present questionnaire 
was developed similarly to the measurement used in the London 
Patient Choice Project (LPCP) and is explained in more detail 
by Garcia-Garzon and colleagues (Garcia-Garzon et al., under 
review). The LPCP investigated the factors influencing patients’ 
socioeconomic choices using a combination of revealed and stated 
preferences (17).
The present questionnaire consisted of hypothetical scenarios 
framed in a realistic way. The scenarios required respondents to 
imagine being in need of a specific medical treatment given a 
certain initial situation. The hypothetical scenarios were a com-
bination of three different factors: procedure, reason for traveling, 
and the country of the destination clinic (Figure 1). Two specific 
procedures were selected from a pool commonly referred to in 
medical travel literature [e.g., Ref. (21)] and aimed to capture 
two distinct levels of invasiveness, whereby “hip replacement” is 
considered to be a less invasive and less life-threatening proce-
dure than “heart valve replacement.” Invasiveness was considered 
important as it should influence the perceived urgency of the 
treatment. The more invasive procedure is assumed to be per-
ceived as more threatening and hence more urgent. Three reasons 
for traveling – quality, waiting time, and cost – were included in 
the questionnaire based on a literature review and consultancy 
expertise that implicated these factors in determining patients’ 
decisions to receive care abroad. Finally, 12 countries were 
selected based on their prospective attractiveness for medical 
travelers. For the purpose of the analyses, these countries were 
grouped into six regions: Northern Europe (Germany and UK), 
Southern Europe (Portugal and Malta), Middle East (Qatar 
and Dubai), Southeast Asia (Thailand and Philippines), Pacific 
(Singapore, New Zealand, and Australia), and the USA as its own 
region. Each scenario specified one out of the two procedures, 
INTRODUCTION
National health care systems differ largely in terms of structure, 
provision of services, quality, and costs. These differences, com-
bined with increased access to transportation across borders, 
and the availability of information brought on by technological 
advances, are leading to the emergence of patient choice, new 
forms of consumerism, and production of health care services (1). 
One dimension of this development is the selective movement of 
patients beyond national borders to pursue medical treatment, 
a phenomenon that has been labeled as “medical tourism” or 
“medical travel” (2).
Though medical travel itself is not new, there has been a 
shift in travel patterns in recent years (2). Wealthy individuals 
traveling abroad to obtain more advanced health care and better 
quality treatment are no longer representative of the situation (3). 
Instead, a rising number of individuals from developed countries 
travel to developing countries for the same purposes. Many of 
them cannot be characterized as affluent individuals but rather 
as conscious consumers seeking affordable high-quality medical 
care (4). In this emerging context, medical travel is defined as 
any patient crossing national borders with the purpose of receiv-
ing treatment that has been determined as essential to maintain 
quality of life by a health professional but may not need to be 
performed urgently.
Estimated numbers of patients traveling abroad for medical 
care vary (5), but all of them indicate an immense growth in this 
phenomenon (4, 6). Despite the expansion of a global health care 
industry and considerable attention from researchers, policy 
makers, and the media, hard evidence-based reports on the flow 
of medical travelers are absent. Although initial estimates were 
based on a limited body of empirical evidence, they were cited 
so often that they became treated as absolute. However, it is now 
recognized that they should be interpreted with caution (6, 7).
Moreover, the majority of existing literature on medical travel 
focused on medical tourism [e.g., Ref. (8, 9)], more specifically on 
traveling for elective procedures, such as cosmetic surgery (2), as 
opposed to traveling for necessary medical procedures [e.g., Ref. 
(10, 11)]. Only a small number of studies have focused on iden-
tifying push factors that make a person elect to travel for medical 
care and pull factors that cause a person to select a particular type 
of treatment (12–14). To date, these factors include treatment 
accessibility in the home country and the nature of the treatment, 
commonly orthopedic, eye, and heart surgery (3). Based on the 
limited available evidence (15, 16), the primary reasons for seek-
ing medical treatment abroad include the prospect of access to 
higher-quality treatment, lower costs, and shorter waiting lists 
(7, 10, 17–19).
Although current literature has been helpful in identifying some 
key factors in decision-making process when it comes to traveling 
FIGURE 1 | Structure of the questionnaire scenarios. After stating their decision to travel for care, participants were asked to tick reasons relevant to their 
decision (in gradient).
January 2016 | Volume 3 | Article 2843
Zhukovsky et al. Evidence-Based Policy for Medical Travel
Frontiers in Public Health | www.frontiersin.org
an advantage in cost, waiting time, or quality and was set in one 
of the 12 destination countries. The dependent variable was the 
participants’ choice to receive care abroad for each scenario.
The permuted combinations of 12 countries, two procedures 
and three factors resulted in a pool of 72 scenarios. Besides the 
demographic items, such as rating of the aspects of local health 
care and socioeconomic status details, each participant was 
presented with a random selection of six scenarios. By doing this, 
a lengthy questionnaire was avoided and a multiplicity of obser-
vations was made possible to be obtained. This approach was 
crucial for another reason: randomizing the scenarios increased 
the independence of observations and decreased the systematic 
variation in the responses that would otherwise arise from a fixed 
order of scenarios.
Sample
Participants were recruited via social media advertising and com-
pleted the questionnaire in English online. Data were excluded if 
participants only completed a fraction of the questionnaire and 
did not answer the questions for all six scenarios or took too much 
or too little time to complete the questionnaire. Valid data were 
obtained from 543 participants, resulting in 3155 observations. 
The majority of the sample were female (67.8%), highly educated 
(74.5%), and European (87.7%). On average, it took participants 
a little more than 7 min to complete the questionnaire. Ethical 
approval was obtained from the Department of Engineering 
Ethics Committee at the University of Cambridge.
Statistical Analysis
Pearson’s Chi-Square tests with contingency tables were used to 
analyze the relationship between the main predictors or demo-
graphic variables with the dependent variable (choice to travel 
for medical care). To extend the analyses to interaction effects of 
procedure, reason, and destination region on the choice to receive 
care abroad, multiple logistic regression was used.
First, chi-square tests and linear regression were used to test 
for associations between demographic control variables and 
the frequency of agreeing to travel for care. For the purposes of 
categorical analyses, Likert scale ratings (1–5) and the destination 
regions were treated as categories (22). Second, goodness-of-fit 
chi-square test was used to test whether there was an overall 
tendency to agree to travel for medical care. Next, a chi-square 
test was used to test for associations between the procedure and 
the indicated choice to travel. The effect was quantified in terms 
of the ratio of the odds of traveling for heart valve and the odds 
of traveling for hip replacement (23, 30). Similar tests were run 
to test for associations between reason or destination region 
with the stated choice to travel. Furthermore, frequencies of the 
reasons indicated as important for the stated decision to travel in 
a given hypothetical scenario were recorded for the most interest-
ing scenarios with unusual response patterns. Specifically, since 
participants were not likely to choose to travel for care to Asia, 
it was important to analyze post-decision information for that 
region to clarify the motivation behind negative decisions. In 
order to clarify the interactions between the predictor variables, 
log-linear analyses were carried out. In particular, interactions 
between main predictors, such as procedure and reason, were 
included alongside with interactions between control variables, 
such as rating of health care aspects in one’s home country, and 
the reason presented in the scenario.
RESULTS
Descriptives
On average, participants rated the quality and the cost of their 
local health care system positive to very positive, and assigned a 
neutral to below neutral rating to the waiting time in their local 
health care system (see Table 1). A small proportion of participants 
(5%) had previous medical travel experience. Overall, two-thirds 
of the responses indicated willingness to travel for medical care, 
when main predictor variables were not taken into account. Most 
participants reported that their income was average compared to 
the income of a fully employed person in the same country.
Stated Choice to Travel by Control 
Variables (Demographics)
Chi-square tests were conducted to test for associations between 
control variables and the decision to travel or not to travel for 
care (see Table 2).
Participants who rated waiting time as more problematic in 
their own country were more likely to opt for medical travel. The 
TABLE 2 | Chi-square statistics for control variables.
Variable df χ2
Gender 1 3.04
Income 4 11.12*
Education 3 19.49**
Ratings of aspects of local health care
Cost 4 8.65
Quality 4 41.24**
Waiting time 4 20.04**
*p < 0.05.
**p < 0.01.
TABLE 1 | Characteristics of study sample (N = 543).
Variable Value Frequency % 
(absolute Nr)
Mean SD
Gender
Female 67.8 (368)
Age 27.6 10.36
Medical travel experience
Yes 5.0 (27)
No 95.0 (516)
Region of origin
Europea 87.7 (470)
Other 12.3 (73)
Education
Master degree, PhD 
or eq.
43.6 (237)
Bachelor degree or eq. 30.9 (168)
Secondary school 19.0 (103)
Higher vocational training 6.5 (35)
Income (n = 542)
Very high 1.7 (9)
Above average 22.1 (120)
Average 43.5 (236)
Low 29.8 (162)
Below poverty 2.8 (15)
Rating of local health careb
Quality 3.7 0.98
Waiting 2.7 1.13
Cost 3.5 1.11
aEurope, Germany, Slovenia, UK, Spain, and other countries.
bValues refer to a Likert scale ranging from 1 to 5, with 1, very negative; 2, negative; 3, 
neutral; 4, positive; 5, very positive.
TABLE 3 | Frequency of deciding for or against medical travel and the 
odds ratios of traveling by reason and procedure.
Across all scenarios (%) OR (95% CI)
Choice to travel (circumstances 
not controlled)
66.9
By procedure
Hip replacement 64.0 Heart valve 1.3 (1.1; 1.6)
Heart valve 69.8 Hip replacement
By reason
Quality 82.0 Quality/waiting time 2.6 (2.1; 3.3)
Waiting time 63.5 Quality/cost 3.7 (3.0; 4.5)
Cost 55.4 Waiting time/cost 1.4 (1.2; 1.6)
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linear regression model reveals a negative trend between the rating 
of the local health care waiting time and the choice to travel for care, 
operationalized as the odds of traveling [F(1,3) = 68.45, p < 0.005] 
with an adjusted R2 of 0.94. Participants who rate waiting time as 
very negative are twice as likely to agree to travel as those who rate 
it as very positive, OR = 2.04 with 95% CI (1.39, 3.00).
No significant correlations were found between the odds 
of agreeing to medical travel and the rating of quality and 
between odds of traveling [F(1,3) = 3.88, r = −0.75, p > 0.05 and 
F(1,3) = 3.68, r = −0.74, p > 0.05, respectively].
Stated Choices to Travel for Medical Care
Without controlling for other factors, in most of the 3155 
scenarios (66.9%) that were presented, participants agreed to 
travel for care, χ2 (1) = 362.29, p < 0.001 (Table 3). A significant 
association was found between the procedure and the choice to 
travel for medical care, χ2 (1) = 12.23, p < 0.001. Participants in 
the heart valve scenario were more likely to travel for care than 
participants presented with hip replacement, which represents 
a small effect of the medical procedure. There was a significant 
association between the reasons for medical travel and the deci-
sion to travel for care: χ2 (2) = 180.16, p < 0.001. Participants were 
most likely to travel for quality, followed by waiting time and cost. 
In addition, there is a significant association between the destina-
tion and the decision to travel for medical care: χ2 (5) = 295.51, 
p < 0.001. Germany or UK (Northern Europe) are the most likely 
destinations, with the odds of agreeing to travel to these countries 
being over three times as high as the odds of traveling to any 
other region (see Figure 2). Participants were less likely to travel 
to Thailand and Philippines (Southeast Asia, odds =  0.72), as 
the odds of other regions, including Southern Europe, Northern 
Europe, USA, and Pacific were at least two times as high as the 
odds of traveling to Southeast Asia (see Figure 2).
The odds of traveling to the Middle East were the second 
lowest (odds = 1.63), being 1.75 times lower than the odds of 
agreeing to travel to the USA, and 5.75 times lower than the 
odds of UK and Germany (Figure 2). The odds of traveling for 
care were higher than 1 for all the regions of destination except 
Southeast Asia, indicating that the number of “yes” replies for 
those regions was higher than the number of “no” replies. For 
Southeast Asia, however, the odds of traveling for care were 
lower than 1, indicating that the likelihood of a participant not 
willing to travel to this region was higher than the likelihood of 
agreeing to travel.
Since the stated preference rates for medical travel were low-
est for Southeast Asia, this region provides some crucial insights 
into factors driving medical traveler’s decisions to go abroad and 
deserves further analysis. A breakdown of the willingness to 
travel to that region by reason (Figure 3, the left y-axis) shows 
that the willingness to travel differs significantly across the three 
reasons when participants are presented with Southeast Asia 
as destination of medical travel, χ2 (2) = 78.84, p < 0.001. The 
decision to travel is significantly more frequent if participants are 
told they would receive higher quality of treatment than if they 
are presented with shorter waiting times or lower costs in Asia. 
To quantify this effect, the odds of traveling to Asia for quality 
(reported on the right y-axis in Figure 3) are 6.5, 95% CI (4.07, 
10.25) times higher than the odds of traveling there for cost and 
FIGURE 3 | Choice to travel (Yes/No frequencies in percent of the 
total) to Southeast Asia by reason on the left y-axis and odds of 
traveling on the right y-axis.
FIGURE 2 | Odds ratios for Northern Europe (N. Europe), Southeast 
Asia (S. Asia), and Middle East (M. East) with 95% CIs. Non-significant 
ORs are not displayed.
January 2016 | Volume 3 | Article 2845
Zhukovsky et al. Evidence-Based Policy for Medical Travel
Frontiers in Public Health | www.frontiersin.org
4.5, 95% CI (2.86, 6.98) times higher than the odds of traveling 
for waiting time.
Those who decided against traveling for care to Asia (310 nega-
tive replies) were presented with a choice of possible reasons that 
they could indicate as important for their previous decision. The 
most commonly indicated reason was that they had little knowl-
edge of the country (see Figure 4A). When given the option to 
state their own reasons in an open question, participants pointed 
out that they had concerns about aspects of quality of care (20 
cases) in Thailand or Philippines (such as hygiene), and that they 
would try to avoid the challenges of traveling so far away (17 
cases) with a medical condition.
When asked whether they would reconsider their decision if 
they were given additional benefits, participants most often (in 
terms of most common response) indicated that they would not 
travel for care under any circumstances (see Figure 4B). However, 
in about a third of the cases, participants stated that they would 
travel if follow-up care in the home country was offered. In 
approximately 20% of the cases, participants were willing to travel 
if a significant other could accompany them. Several participants 
emphasized the importance of quality in the open questions as 
they agreed to travel for care if they would be provided with 
satisfactory assurance of high-quality treatment abroad, such as 
the approval by the local authorities or doctors.
Stated Choice to Travel by Interaction 
between Reason and Procedure
The hypothesis that there are differences between the frequencies 
of agreeing to travel across combinations of different factors was 
tested using log-linear analyses. First, the interaction between 
reason and procedure was analyzed. The three-way log-linear 
analysis produced a final model that retained all effects. The 
model shows that the highest-order interaction was significant 
[reason × procedure × choice to travel, χ2 (1) = 16.59, p < 0.001]. 
To break down this effect, separate chi-square tests on the proce-
dure and choice to travel for care were performed separately for 
cost, quality, and waiting time (reasons). A significant association 
between the procedure (heart valve and hip replacement) and 
waiting time was found, χ2 (1) = 27.79, p < 0.001.
The odds of deciding in favor of medical travel in a hypotheti-
cal scenario with shorter waiting time were two times higher, 95% 
CI (1.54, 2.56) for heart valve than for hip replacement. In brief, it 
was found that while there are no interactive effects between pro-
cedure and cost or procedure and quality, the decision to travel 
given the waiting time scenario depends on the type of procedure. 
Reduced waiting time had a significantly stronger influence for 
the more invasive procedure, since heart valve replacement (in 
interaction with waiting time) was associated with higher odds 
of traveling for care (see Figure 5).
DISCUSSION
Key Findings
Decision-making underlying medical travel is complex and 
influenced by a combination of factors. The objective of this study 
was to explore the contribution of certain factors that individuals 
consider when formulating their decision for or against traveling 
abroad for medical treatment. A new experimental tool was 
designed to test the relative influence of different destinations, 
procedures, reasons, and interactions of these factors on stated 
choices to travel for medical care.
Evidence emerging from this novel approach confirmed 
some of the findings in the previous literature and provided 
new insights into decision-making of non-patients, focusing 
on medical travel rather than medical tourism. Key findings 
included that (1) individuals display high willingness to travel 
for medical care; (2) quality is the most important and cost is 
the least important stated factor; (3) waiting time and procedure 
have interactive effects on decisions to go abroad for care; and (4) 
Northern Europe is exceptionally popular, followed by the USA 
and Southern Europe, though potential travelers would consider 
going to locations that were chosen less frequently, such as Asia, 
if certain conditions (notably assurance of higher quality) were 
provided. These findings were in line with the results of the 
control variable analysis.
FIGURE 5 | Yes/no frequencies (in percent of the total) across 
procedure and reason.
FIGURE 4 | (A) Number of times a statement was indicated as important in deciding not to travel to Asia (maximum of 310 times possible). (B) Number of times a 
statement was indicated in response to “I would travel to Asia if …” (maximum of 310 possible).
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Control Variables
Although several associations exist between control variables and 
the stated willingness to travel exist, they do not provide evidence 
strong enough to be of interest. Indeed, they are much weaker 
than the associations between regions of destination and choice to 
travel as well as reason and the choice to travel. However, greater 
dissatisfaction with waiting times for local health care opera-
tionalized in the corresponding lower ratings reliably predicted 
higher odds of choosing to travel for medical care, as revealed by 
the regression analyses. Similarly, dissatisfaction with the quality 
and cost of local health care drives participants to go abroad for 
medical care, as shown by moderately strong correlation between 
the rating of quality or rating of cost and choice to travel.
Assuming that participants have the same priorities when 
receiving health care abroad and at home, this finding supports 
the result that quality and waiting time significantly influence 
participants’ decision-making. These factors influence their deci-
sion-making directly (as shown in the analysis of the hypothetical 
scenarios) and indirectly, when the participants are considering 
their local health care. Moreover, the answers of potential medi-
cal travelers in hypothetical scenarios were found to agree with 
the actual choices of medical travelers (London Patient Choice 
Report, 3). Since stated preference paradigm reliably indicated 
the revealed preference patterns, the conclusion that individuals 
value waiting time over cost can be generalized and holds even 
for expected revealed preference patterns.
Individual Decisions for Medical Travel
Regardless of the combination of the motivating factors, 
participants were more likely to agree to travel for care than 
to refuse to travel. This confirms the trend that we find in the 
development of medical travel and tourism over the last decade: 
more and more people go abroad for medical care. Among 
UK citizens specifically, the number of medical travelers in 
2010 was 6 times as large as that in 2000 (5). However, infer-
ences about the willingness to travel for care must not be too 
quick, since the scenarios in this study were framed to offer 
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advantageous and simplified combinations to the participants. 
When actually in need of a specific treatment and consider-
ing medical travel, individuals face more diverse conditions 
that might decrease their willingness to go abroad for care. 
Decision-making under conditions of experienced time pres-
sure tends to be guided by affective evaluation rather than by 
analytic cognitive processes (24), especially if the incentives 
for using the latter are low. When participants are presented 
with positive information, such as a certain type of advantage, 
individuals’ global affective evaluation of the choices becomes 
more positive (25). Therefore, participants in our study might 
have agreed to medical travel more easily than if they would 
have considered both the benefits and the costs. Against this 
explanation of high willingness to travel speaks the fact that 
many participants indicated reasons for their decision (not) 
to travel for care. While it is conceivable that this may be a 
post hoc rationalization of an affective decision, it seems more 
plausible that the decisions were reasoned rather than affective 
since on average participants spent over 7 min completing the 
questionnaire and should not have experienced any externally 
imposed time pressure.
The weak association between the type of procedure and 
the decision for or against medical travel shows that the 
treatment procedure is not important enough to modify the 
outcome variable by itself. This result may be due to the fact 
that our young sample (mean age =  27.6) was not sensitive 
to the potential complications associated with the respective 
procedures when considering it in combination with a variety 
of other factors. However, when procedure was combined with 
waiting time, participants realized that heart valve transplant 
was more urgent than hip replacement and displayed higher 
willingness to travel for the more invasive procedure. Different 
types of procedures as well as more differentiated sample age 
need to be considered in future study replications to gain more 
conclusive results.
The effects of the various reasons on the decision to travel 
differ significantly: quality has the strongest and cost the weakest 
association with deciding to receive medical treatment abroad 
with waiting time being of intermediate importance compared 
to the other two factors. These associations corroborate the body 
of evidence that quality is a key reason for receiving medical care 
(10, 19, 26).
More importantly, this study indicates that participants are 
more motivated to travel for care by the promise of shorter wait-
ing times than by the promise of lower costs of the treatment. 
This effect pattern is invariant across all income categories, 
which means that cost may play an inferior role regardless of the 
respondent’s economic background. Therefore, both those who 
saw themselves as falling in above and below average income cat-
egories are guided by the same considerations, assigning waiting 
time a more important role than financial issues.
The effects of different reasons are robust across all education 
degrees. They may be unaffected by control variables because 
individuals follow the socially accepted maxim “health is more 
important than money” and place waiting time (which often goes 
along with deterioration of health) and quality of treatment above 
cost. To counteract some effects of social desirability, the study 
was conducted online and participants’ personal information 
remained anonymous.
In previous reports, it has been often claimed that considera-
tions of costs are the driving force behind the decision-making 
process (7, 17). However, this assumption has not been empiri-
cally supported to date (2) and might have been adopted from 
country-specific or economic cases, where affordability is a major 
concern for patients. The USA represent a typical example of a 
location where cost-saving opportunities would increase interest 
in medical travel, as the rise in the cost of local health care and 
economic recession lead individuals to seek treatment abroad 
(27). Results from our predominantly European sample show, 
however, that cost is less important than quality and waiting time 
for a treatment, likely linked to less daily concern about such costs 
given national health finance structures.
With respect to the areas of destination, we discovered a strong 
association between deciding for medical travel and the destina-
tion countries. The particular interest in the UK and Germany 
might at first glance be a result of proximity. Given that also USA, 
Portugal, and Malta were associated with a high number of posi-
tive answers, our results more likely reflect a general preference of 
European or “Western” countries due to reputation and cultural 
familiarity.
The popularity of Europe as a region for medical travel was 
also found in descriptive reports by Hanefeld and colleagues (5) 
who pointed out that between 2000 and 2010, 72% of all medi-
cal journeys from the UK were to Western, Eastern or Central 
Europe, noting an increase in patients going to Asia and India. 
Our sample aimed to represent all parts of Europe rather than 
focus on the UK and thus found that Asia is, contrary to Hanefeld’s 
findings, a less preferred location. Our results partially contradict 
the conclusions of previous studies: Gallup (19) found that only 
54% of European Union citizens were “open to travel to another 
EU country to seek medical treatment.” As our study shows, 
Europeans display much stronger readiness to travel within EU 
borders: 69.0% were willing to travel to Malta or Portugal and 
90.4% agreed to travel to Germany or UK regardless of procedure 
and reason. Even tempered for potential effects of this being a 
stated preference rather than an observed behavior, this would 
seem to indicate much greater openness to such participation.
Participants from all over the world are less willing to travel to 
the Middle East, Pacific countries (Australia, New Zealand, and 
Singapore) and Southeast Asia (Thailand and Philippines). The 
key reason not to travel to Asia is the perceived lack of quality of 
health care. While most replies indicate unwillingness to travel 
to Asia for lowers costs or shorter waiting time, the promise of 
better quality in Asia reverses the trend and results in a surpris-
ingly high number of positive replies (67.9%, see Figure 3). Given 
that participants are attracted by high quality of medical care, 
it is reasonable to assume that they prefer Europe and the USA 
due to the high-quality standards and the high reputation of the 
clinics there (11). As previous research points out, all aspects 
of quality of treatment, including success rates of operations, 
doctors’ experience, and rates of complications, are considered 
by actual medical travelers. When considering destinations of 
medical travel, such as Thailand and Philippines, travelers are first 
of all looking for quality. Moreover, they are concerned that the 
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long journey and being in an alien environment could negatively 
influence their health.
For some participants, the decision against medical travel to 
Asia is not final. The possibility of receiving follow-up care in 
their home country would change their decision in one-third of 
the cases. The assurance of receiving follow-up care at home may 
alleviate the concerns that individuals have about the risks of pro-
cedures abroad. Although travelers were skeptical about the qual-
ity of treatment, they also indicated that they had little knowledge 
about the country (for approximately 50% of replies) and would 
reconsider their decision if they had sufficient favorable evidence 
(in form of research, personal reports, doctoral recommenda-
tion, or information about the abroad doctors’ qualifications), 
suggesting that the quality of treatment in Asia is adequate. In 
many cases (for approximately 20% of replies), the comfort of 
being with their family was so important to participants that they 
would change their mind and travel to Asia for care if they could 
bring a significant other with them.
Potential travelers value quality and sometimes require cred-
ible assurances of Asian clinics fulfilling certain standards (Kácha 
et al., under review) to be motivated to travel there. Another 
important concern is, given the highly European sample, distance 
to Asian countries. Transportation is burdensome and discour-
ages people from traveling, and also makes it more difficult for 
family and friends to visit the patient, resulting in pressure on 
convenience as the ultimate lever. Though the presence of a 
significant other does not influence physical health, it does have 
an effect on mental health and well-being of the patients (28, 29) 
and is, thus, an important factor to consider for policymakers, 
should medical travel be looked at as a tool for health systems.
Interactive Effects
Previously, we have seen that the overall differences in willing-
ness to travel for hip or heart valve replacement are rather 
small, though statistically significant (23). There is no variation 
in willingness to travel between procedures and cost or quality 
as reasons (see Figure 5). However, procedure does play a role 
when the participants consider waiting time as a reason to go 
abroad for medical care, and in that case willingness to travel for 
the invasive procedure (heart valve) was higher than willingness 
to travel for the less invasive hip replacement. When presented 
with a more invasive procedure, individuals feel under time pres-
sure to receive treatment and may be driven toward receiving 
care abroad if foreign clinics reduce waiting time. A limitation 
of this conclusion may be that it is not simply the invasiveness 
of procedure that motivates individuals to go abroad whenever 
the waiting time in their home country is long, but rather the 
diminishing quality of life or the risks of delaying the treatment 
that differ across procedures.
Limitations
The sample comprises 543 participants, and every participant 
received 6 questions, hence resulting in 3258 (3172 valid) obser-
vations. The fact that there were six binary yes/no questions per 
each participant created a problem for the assumption of inde-
pendence that is fundamental for chi-square contingency tests 
and log-linear analyses. The following argument can be made 
in favor of independence of individual data points: even though 
six questions were given to the same participant, the questions 
consisted of a different combination of procedure, reason, and 
destination region. Thus, the same participant viewed a differ-
ent question every time. The dimensions of the questions were 
separated and grouped together only at the stage of analyzing the 
data. More importantly, the questions were randomly assigned to 
the participants, resulting in random differences in responses and 
allowing for a more strict control of independence.
This argument still leaves open the question of whether each 
participant’s answer to, e.g., a question about quality was not 
influenced by their previous answer to a question involving qual-
ity. It is possible to view every set of six questions per person as a 
repeated measures approach, where the participant is presented 
with the same factor (e.g., hip replacement) over and over again. 
A better analytic approach must relax the assumption of inde-
pendence and allow for possible interactions across individual 
observations.
Finally, the sample was mostly European and more data 
from all over the world would be required to increase gener-
alizability. The Brazil, Russia, India, and China (BRIC) states 
were intentionally left out and data on Russia were collected. 
The geographical distribution of the sample is the result of the 
data collection method that can be presented both as a strength 
and as a limitation: online social media advertising allows 
the researchers to reach out to a wide pool of participants 
from different regions that would otherwise be hard to access. 
However, it also limits the target group to English-speaking 
individuals who are active on social media and are responsive 
to the questionnaire adverts. The group primarily targeted in 
this way consists of young, student-linked people in European 
countries. As previously shown, our participants came from dif-
ferent perceived income categories, which somewhat increases 
the generalizability of findings. Furthermore, the sample is 
predominantly female. Given these limitations in the sampling 
method, policymakers have to be careful in utilizing such evi-
dence as even a sophisticated, highly adapted approach to mod-
eling raised concerns about appropriate use of the data. Highly 
relevant factors of minority groups and choices – that is, small 
but very important factors and outcomes may be missed due to 
large majority factors. This was particularly the case for medical 
choices between age groups, for individuals from regions highly 
affected by conflict, and also by under-represented countries in 
the data whose patterns may not fit those of highly represented 
countries, which also presented a proxy for national economic 
and health service standards.
CONCLUSION
Our findings provide crucial insights into the factors driving the 
decision-making of potential medical travelers. Since the most 
important factor is the quality of treatment, it is crucial that the 
quality standards are upheld in the destination country and cred-
ible assurances of a high-quality treatment are provided in order 
for individuals to consider going abroad for care. Geographical 
preferences found in this study largely reflect the finding that 
participants prioritize quality.
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Potential travelers’ decisions are not always influenced by 
any one factor in isolation. Instead, they can be the result of an 
interaction between several factors, such as the invasiveness of 
the procedure and the waiting time. While waiting for a more 
invasive procedure does not influence the willingness to travel 
for care on its own, it becomes important when considering the 
waiting time in one’s home country and abroad.
Participants’ decisions not to travel for care are often not final. 
Even if an individual does not think favorably of medical travel, 
they are often willing to consider trade-offs. For instance, they 
might change their mind about traveling to an Asian country if 
their concerns about follow-up care are addressed. Offering certain 
advantages, such as assurances of quality, the possibility of follow-
up care at home or the presence of a loved one in the destination 
country may convince even those who initially were against going 
abroad for medical care. Though this may be seen as crucial insight 
from an industry perspective, it is critical that the global health 
policies consider this when setting minimum standards with the 
goal of protecting potential patients from being misled and put at 
risk. If treated carefully, the insights into the factors that influence 
patient choice obtained in this study could be valuable in tackling 
the challenges arising with the implementation of new policies, 
such as cross-border health care directive in the EU.
As it is clear that medical travel is likely to expand in the near 
future, careful use of the insights into decision-making from 
our study and further work on this topic is necessary to inform 
relevant health policies. Understanding more about what drives 
these decisions is one of many important factors that must be built 
into such policies, as these present the opportunity to safeguard 
against potential risk as well as to ensure that any expanded access 
to care through medical travel offers genuine benefits to health 
and health services.
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